SUSPENDED

Aromatherapy Oil Associated for Managing Anxiety and Pain During Bone Marrow Biopsy Procedures

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This clinical trial evaluates whether using aromatherapy can reduce pain and anxiety for cancer patients during routine biopsy procedures. Because of the discomfort associated with a bone marrow aspirate and biopsy (BMAB), many patients have significant anxiety in addition to their pain. With the current background of the opioid crisis, researchers have been looking for different ways to treat pain and anxiety in cancer patients without using medications that have a risk for abuse. Recent research suggests that using lavender aromatherapy may be an effective and more affordable treatment for anxiety and pain in patients. Information gathered from this study may help researchers determine whether using aromatherapy may help to manage pain and anxiety during biopsy procedures for cancer patients.

Official Title

Aromatherapy Oil Associated Changes on Anxiety and Pain During Bone Marrow Biopsy Procedures

Quick Facts

Study Start:2024-08-23
Study Completion:2026-06-25
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:SUSPENDED

Study ID

NCT06581211

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients must have the ability to understand and sign a written informed consent document, and be willing to follow protocol requirements
  2. * Ability to read and understand English for patient reported outcomes
  3. * Age \>= 18 years
  4. * Eastern Cooperative Oncology Group (ECOG) performance status ≤ 1
  5. * Willingness to comply with all study interventions of essential oil aromatherapy
  6. * Anxiety \> 3 on a 0-10 visual analog scale regarding the bone marrow biopsy/aspirate procedure
  7. * The study is open to all participants regardless of gender, race, or ethnicity
  1. * Allergy to lavender oil, linalool oil, jojoba oil
  2. * Previous enrollment in this study
  3. * Uncontrolled respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD)
  4. * Mental incapacitation (ex. stroke, brain metastasis etc.) that would cause inability to follow directions, in the opinion of the investigators
  5. * Ongoing uncontrolled active psychiatric condition that would interfere in the conduct of the study (e.g., mood disorders, anxiety, psychosis disorders, or substance use), as determined by the patient's primary cancer team.
  6. * If a patient has a history of a psychiatric disorder, we will contact their primary cancer team to determine if their condition is controlled or uncontrolled, and if it will interfere with the study
  7. * Recent changes in the past 2 weeks to medications prescribed for pain or anxiety
  8. * Abnormal smelling abilities due to sinus infections, long COVID, etc.

Contacts and Locations

Principal Investigator

Richard T Lee
PRINCIPAL_INVESTIGATOR
City of Hope Medical Center

Study Locations (Sites)

City of Hope Medical Center
Duarte, California, 91010
United States
City of Hope at Lennar
Irvine, California, 92618
United States

Collaborators and Investigators

Sponsor: City of Hope Medical Center

  • Richard T Lee, PRINCIPAL_INVESTIGATOR, City of Hope Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-08-23
Study Completion Date2026-06-25

Study Record Updates

Study Start Date2024-08-23
Study Completion Date2026-06-25

Terms related to this study

Additional Relevant MeSH Terms

  • Hematopoietic and Lymphatic System Neoplasm
  • Malignant Solid Neoplasm